Resources

  Following a broad domestic and international search, with the assistance of our Clairfield partners, DZG Investments, the Australian subsidiary of the  Goubuli Group, a Chinese food and beverage company, has acquired an 80% stake in BJP Laboratories, a leading Australian contract manufacturer of listed medicines. InterFinancial assumed a lead advisory role on the transaction […]

Clairfield International has further expanded its global M&A presence through a new partnership in the United States with Atlanta-based investment bank Croft & Bender. Croft & Bender provides mergers and acquisitions, private capital-raising, and financial advisory services to middle-market and emerging growth companies. Croft & Bender will be exclusive partner for Clairfield in the United […]

The board of directors of Clairfield International is pleased to announce the appointment of Alexander Klemm as executive chairman and Thierry Chetrit as vice chairman, with immediate effect. Alex joined Clairfield in 2015 and was appointed vice chairman in 2016. Alex has advised many corporate and private equity clients in M&A and capital markets transactions […]

Charm Health is Australia’s leading supplier of specialist medical oncology e-health systems, with its solutions used by leading public and private health providers of cancer care. OneVentures first invested in Charm Health in 2013 through OneVentures Innovation Fund I and has been instrumental in supporting the Charm Health team in increasing market share and reinforcing […]

InterFinancial recently turned 30. The original company was registered on 6th August 1987 and Ray Magill, one of the founders, was among those attending the birthday event. A reception was held at the Queensland Art Gallery and Gallery of Modern Art to celebrate the occasion with partners, clients, and friends sharing thoughts on the past […]